ADG126 not checked

Adagene Inc

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1/2 trial completes
Trials
1 active
2 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“ADG126 is an anti-CTLA-4 fully human monoclonal antibody that specifically binds to human CTLA-4.”In the company’s words, NCT05405595 on ClinicalTrials.gov
Tested for
Advanced/Metastatic Solid Tumors
Main trialPhase 1/2
“This is a Phase 1b/2, open-label, dose escalation, dose expansion and dose optimization study to evaluate the safety, tolerability, PK, and immunogenicity of ADG126-pembrolizumab combination regimens in patients with advanced/metastatic solid tumors. The study drug ADG126 is an anti-CTLA-4 fully human monoclonal antibody that specifically binds to human CTLA-4. Pembrolizumab is a PD-1 receptor-blocking antibody (a humanized IgG4 monoclonal antibody).”In the company’s words, NCT05405595 on ClinicalTrials.gov

Other drugs for Advanced/Metastatic Solid Tumors

All 29 drugs for Advanced/Metastatic Solid Tumors

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 1/2Recruiting 30 Jun 2027 ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
Phase 1/2Completed 29 Jan 2024 ADG126, ADG126 in Combination With Anti PD1 Antibody, and ADG126 in Combination With ADG106 in Advanced/Metastatic Solid Tumors
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow ADG126

Following is part of Solo: you see every change to ADG126 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in